Author

C. Vanhove

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:development & morphogenesis· 2 Approach:genetic perturbation / CRISPR· 2 Organism:mouse· 2 Organism:Xenopus· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

D. Creytens· 2 shared D. Tulkens· 2 shared K. Vleminckx· 2 shared S. Demuynck· 2 shared T. Naert· 2 shared A. Thiran· 1 shared B. Alman· 1 shared B. Descamps· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. Creytens

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Sterile triggers drive joint inflammation in TNF and IL-1beta dependent mouse arthritis models

A. Thiran, I. Petta, G. Blancke, M. Thorp, G. Plankaert, M. Jans, V. Andries, K. Barbry, T. Hochepied, C. Vanhove, E. Gracey, E. Dumas, T. Manuelo, I. Josipovic, G. van Loo, , L. Vereecke

This study shows that joint inflammation in TNF and IL-1beta mouse arthritis models occurs independently of the microbiota, while TNF-driven gut inflammation depends on it.

bioRxiv · Jan 31, 2023Immunology

CRISPR-SID: identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping

T. Naert, D. Tulkens, T. Van Nieuwenhuysen, J. Przybyl, S. Demuynck, M. van de Rijn, M. Al Jazrawe, B. Alman, P. J. Coucke, K. De Leeneer, C. Vanhove, S. N. Savvides, D. Creytens, K. Vleminckx

This paper introduces CRISPR-SID, a method to identify tumor dependencies in Xenopus models, revealing EZH2 as a druggable target for desmoid tumors.

bioRxiv · Sep 1, 2021Cancer Biology

Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers fluorobiphenylglutamine

T. Baguet, J. Verhoeven, G. Pauwelyn, J. Hu, P. Lambe, S. De Lombaerde, S. Piron, S. Donche, B. Descamps, I. Goethals, C. Vanhove, F. De Vos, M. H. Beyzavi

This paper develops and evaluates two novel PET tracers, [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine, for imaging glutamine metabolism in tumors, showing promising in vitro and in vivo results.

bioRxiv · Feb 14, 2020Cancer Biology

RBL1 (p107) functions as tumor suppressor in glioblastoma and small-cell pancreatic neuroendocrine carcinoma

T. Naert, D. Dimitrakopoulou, D. Tulkens, S. Demuynck, R. Noelanders, L. Eeckhout, G. Van Isterdael, D. Deforce, C. Vanhove, J. Van Dorpe, D. Creytens, K. Vleminckx

This study uses CRISPR/Cas9 in Xenopus tropicalis to show that RBL1/p107 compensates for RB1 loss in driving specific cancers like SC-PaNEC and retinoblastoma.

bioRxiv · Jan 23, 2019Cancer Biology